Hypertension in Pregnancy

Papers
(The TQCC of Hypertension in Pregnancy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial37
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China29
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates18
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials16
Identification risk factors for perinatal complications among pregnant women with pulmonary arterial hypertension16
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients14
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk12
Correction12
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway11
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review11
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section11
Targeting oxidative stress in preeclampsia8
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio8
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy8
Umbilical cord-derived exosomal miR−548 is involved in driving preeclampsia pathogenesis by Inhibiting trophoblast cells invasion7
Bioelectrical impedance–derived extracellular fluid expansion and perinatal outcomes in preeclampsia5
The role of early second trimester maternal serum cadherin-11 levels in the prediction of preeclampsia5
A nomogram for preeclampsia risk prediction in the first trimester: a nested case-control study5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
SII serves as an independent diagnostic indicator for GDM and is regulated by placental 5-HT/NF-κB signaling4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study4
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood4
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter4
0.054264068603516